NPS PHARMACEUTICALS INC's ticker is and the CUSIP is 62936P953. A total of 2 filers reported holding NPS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $1,717,000 | +14.6% | 48,000 | -16.7% | 0.00% | 0.0% |
| Q3 2014 | $1,498,000 | +0.9% | 57,600 | +28.3% | 0.00% | 0.0% |
| Q2 2014 | $1,484,000 | -6.8% | 44,900 | -15.6% | 0.00% | 0.0% |
| Q1 2014 | $1,592,000 | -28.6% | 53,200 | -27.6% | 0.00% | -33.3% |
| Q4 2013 | $2,231,000 | +111.3% | 73,500 | +121.4% | 0.00% | +50.0% |
| Q3 2013 | $1,056,000 | +215.2% | 33,200 | +49.5% | 0.00% | +100.0% |
| Q2 2013 | $335,000 | – | 22,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 53,600 | $1,604,000 | 0.03% |
| Citadel Advisors | 53,200 | $1,592,000 | 0.00% |